Alivus Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed the exchanges that its Board of Directors will meet on Friday, August 1, 2025 to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2025 (Q1 FY26). As per SEBI's Insider Trading Regulations, the trading window for designated persons has been closed from June 30, 2025 to August 3, 2025. This is a routine compliance filing ahead of the quarterly results announcement and does not contain any financial figures.
No direct impact on stock price from this filing — it is a procedural disclosure. Investors should watch for the Q1 FY26 results on August 1, 2025, which could move the stock depending on performance versus expectations.